Seeking Alpha

Pfizer (PFE -0.3%) receives EU approval to broaden the use of its Prevenar 13 drug for...

Pfizer (PFE -0.3%) receives EU approval to broaden the use of its Prevenar 13 drug for Pneumococcal Disease (PD) to children aged 6-17 from infants and young children. PD is an infection that can cause pneumonia, an infection of the blood, middle-ear infection and bacterial meningitis. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs